These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 30284724)

  • 1. Low protein diets for non-diabetic adults with chronic kidney disease.
    Hahn D; Hodson EM; Fouque D
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001892. PubMed ID: 30284724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low protein diets for non-diabetic adults with chronic kidney disease.
    Hahn D; Hodson EM; Fouque D
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD001892. PubMed ID: 33118160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein restriction for diabetic kidney disease.
    Jiang S; Fang J; Li W
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014906. PubMed ID: 36594428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial interventions for preventing and treating depression in dialysis patients.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive agents for treating IgA nephropathy.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral versus oral iron therapy for adults and children with chronic kidney disease.
    O'Lone EL; Hodson EM; Nistor I; Bolignano D; Webster AC; Craig JC
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD007857. PubMed ID: 30790278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
    Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for weight loss in people with chronic kidney disease who are overweight or obese.
    Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary interventions for adults with chronic kidney disease.
    Palmer SC; Maggo JK; Campbell KL; Craig JC; Johnson DW; Sutanto B; Ruospo M; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011998. PubMed ID: 28434208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.
    Hahn D; Hodson EM; Hamiwka LA; Lee VW; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004290. PubMed ID: 31840244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
    Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD011798. PubMed ID: 30246878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home versus in-centre haemodialysis for people with kidney failure.
    Cheetham MS; Ethier I; Krishnasamy R; Cho Y; Palmer SC; Johnson DW; Craig JC; Stroumza P; Frantzen L; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2024 Apr; 4(4):CD009535. PubMed ID: 38588450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose targets for preventing diabetic kidney disease and its progression.
    Ruospo M; Saglimbene VM; Palmer SC; De Cosmo S; Pacilli A; Lamacchia O; Cignarelli M; Fioretto P; Vecchio M; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010137. PubMed ID: 28594069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for improving sleep quality in people with chronic kidney disease.
    Natale P; Ruospo M; Saglimbene VM; Palmer SC; Strippoli GF
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012625. PubMed ID: 31129916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Education programmes for people with chronic kidney disease and diabetes.
    Cashmore BA; Cooper TE; Evangelidis NM; Green SC; Lopez-Vargas P; Tunnicliffe DJ
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD007374. PubMed ID: 39171639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
    Cooper TE; Teng C; Tunnicliffe DJ; Cashmore BA; Strippoli GF
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD007751. PubMed ID: 37466151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
    Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
    Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012467. PubMed ID: 33314078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.